Depression in Cancer Patients

Primary Care - Clinics in Office Practice

Volumn 36, Issue 4, 2009, Pages 703-719

  Snyderman, Danielle ^a   Wynn, Daisy ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cancer; Caregiver depression; Depression; Suicide; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DEXAMPHETAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; INTERFERON; METHYLPHENIDATE; MIRTAZAPINE; NORTRIPTYLINE; OPIATE; PAROXETINE; PLACEBO; PSYCHOSTIMULANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TAMOXIFEN; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANTICHOLINERGIC EFFECT; APPETITE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CAREGIVER BURDEN; CHILDHOOD CANCER; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; EVENING DOSAGE; FATIGUE; HEART ARRHYTHMIA; HOT FLUSH; HUMAN; INSOMNIA; MAJOR DEPRESSION; MELANOMA; NAUSEA; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PATIENT CARE; PATIENT COMPLIANCE; PREVALENCE; PRIAPISM; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; QUALITY OF LIFE; RESTLESSNESS; REVIEW; RISK ASSESSMENT; SCREENING TEST; SEDATION; SIDE EFFECT; SLEEP; STEADY STATE; SUICIDE; VOMITING;

CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; NEOPLASMS; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PSYCHOTHERAPY; QUALITY OF LIFE; RISK FACTORS; UNITED STATES;

EID: 71549163767     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2009.07.008     Document Type: Review

References (80)

1. Jacobsen P., and Jim H. Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin 58 (2008) 214-230
2. Pirl W., and Roth A. Diagnosis and treatment of depression in cancer patients. Oncology 13 9 (1999) 1293-1301
3. Pirl W. Evidence report on the occurrence, assessment and treatment of depression in cancer patients. J Natl Cancer Inst Monogr 32 (2004) 32-39
4. Massie M.J. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32 (2004) 57-71
5. Jackson C.W., and Jackson K.H. Comorbid depression in adult oncology. J Pharm Pract 20 (2007) 360-367
6. House A., Dennis M., Magridge L., et al. Mood disorders in the first year after stroke. Br J Psychiatry 158 (1991) 83-92
7. Morris P.L., Robinson R.G., Andrzejewski P., et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry 150 1 (1993) 124-129
8. Mallik S., Krumholz H.M., Lin Z.Q., et al. Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation 111 (2005) 271-277
9. Schleifer S.J., Macari-Hinson M.M., Coyle D.A., et al. The nature and course of depression following myocardial infarction. Arch Intern Med 149 (1989) 1785-1789
10. Makrilia N., Indeck B., Syrigos K., et al. Depression and pancreatic cancer and cancer: a poorly understood link. JOP J Pancreas (Online) 10 1 (2009) 69-76
11. Boyd A.D., and Riba M. Depression and pancreatic cancer. J Natl Compr Canc Netw 5 1 (2007) 113-116
12. Kornstein S.G. The evaluation and management of depression in women across the life span. J Clin Psychiatry 62 Suppl 24 (2001) 11-17
13. Miaskowski C. Gender differences in pain, fatigue, and depression in patients with cancer. J Natl Cancer Inst Monographs 32 (2004) 139-143
14. DeFlorio M.L., and Massie M.J. Review of depression in cancer: gender differences. Depression 3 (1995) 66-80
15. Kravitz R.L., and Ford D.E. Introduction: chronic medical conditions and depression-the view from primary care. Am J Med 121 11 Suppl 2 (2008) S1-S7
16. Wagner J, Allen N, Melkus D, et al. Depression treatment and insulin sensitivity in adults at risk for type 2 diabetes [abstract]. American Diabetes Association: 69th scientific sessions. June, 2009.
17. Frasure-Smith N., Lesperance F., Irwin M.R., et al. Depression, C-reactive protein and two year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 62 4 (2007) 302-308
18. Jehn C.F., Kuehnhardt D., Bartholomae A., et al. Biomarkers of depression in cancer patients. Cancer 107 11 (2006) 2723-2729
19. Turner-Cobb J.M., Sephton S.E., Koopman C., et al. Social support and salivary cortisol in women with metastatic breast cancer. Psychosom Med 62 (2000) 337-345
20. Ariyo A.A., Haan M., Tangen C.M., et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 102 15 (2000) 1773-1779
21. Holmes J., and House A. Psychiatric illness predicts poor outcome after surgery for hip fracture: a prospective cohort study. Psychol Med 30 (2000) 921-929
22. Hjerl K., Andersen E., Kieding N., et al. Depression as a prognostic factor for breast cancer mortality. Psychosomatics 44 (2003) 24-30
23. Goodwin J., Zhang D., and Ostir G. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc 52 1 (2004) 106-111
24. Steel J., Geller D., Gamblin C., et al. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol 25 (2007) 2397-2405
25. Prieto J.M., Atala J., Blanch J., et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 23 25 (2005) 5878-5880
26. Robinson J., and Crawford G. Identifying palliative care patients with symptoms of depression: an algorithm. Palliat Med 19 (2005) 278-287
27. Qaseem A., Snow V., Shekelle P., et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med 148 2 (2008) 141-146
28. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Guildelines for supportive care. Available at:. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp Accessed June 29, 2009
29. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (1994), American Psychiatric Association, Washington, DC
30. Simon G.E., and Von K.M. Medical co-morbidity and validity of DSM 1V depression criteria. Psychol Med 36 (2006) 27-36
31. Schwenk T. Cancer and depression. Primary Care: Clinics in Office Practice 25 2 (1998) 505-513
32. Smith G., and Toonen T. Primary care of the patient with cancer. Am Fam Physician 75 8 (2007) 1207-1214
33. Guo Y., Musselman D., Mantunga A., et al. The diagnosis of major depression in patients with cancer: a comparative approach. Psychosomatics 47 5 (2006) 376-384
34. Mitchell A. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 25 29 (2007) 4670-4681
35. Hoffman M., and Weiner J. Is Mrs. S depressed? Diagnosing depression in the cancer patient. J Clin Oncol 25 19 (2007) 2853-2856
36. Mahoney J., Drinka T.J.K., Abler R., et al. Screening for depression: single question versus GDS. J Am Geriatr Soc 9 (1994) 1006-1008
37. Chochinov H.M., Wilson K.G., Enns M., et al. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry 154 (1997) 674-675
38. Ohno T., Noguchi W., Nakayama Y., et al. How do we interpret the answer "neither" when physicians ask patients with cancer "are you depressed or not?". J Palliat Med 9 4 (2006) 861-865
39. Mulrow C.D., Williams Jr. J.W., Chiquette E., et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med 108 1 (2000) 54-64
40. Henry N.L., Stearns V., Flockhart D.A., et al. Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. Am J Psychiatry 165 (2008) 1251-1255
41. Shimizu K., Akechi T., Shimamoto M., et al. Can psychiatric intervention improve major depression in very near end-of-life cancer patients?. Palliat Support Care 5 (2007) 3-9
42. Jackson V, Block S. Psychostimulants in palliative care. Facts Facts and Concept #61: 2002. End-of-Life/Palliative Education Resource Center. Available at: www.eperc.mcw.edu.
43. Olin J., and Masand P. Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 37 1 (1996) 57-62
44. Sood A., Barton D.L., and Loprinzi C.L. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care 23 (2006) 35-40
45. Stockler M., O'Connell R., Nowak A., et al. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol 8 7 (2007) 603-612
46. Loprinzi C.L., Kugler J.W., Sloan J.A., et al. Venlafaxine in management of hot flashes in survivors of breast cancer:a randomized controlled trial. Lancet 356 (2000) 2059-2063
47. Musselman D.L., Lawson D.H., Gummick J.F., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344 (2001) 961-966
48. Akechi T., Okuyama T., Onishi J., et al. Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev 2 (2008) Art. No.: CD005537
49. Williams S., and Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 94 (2006) 372-390
50. Strong V., Waters R., Hibberd C., et al. Management of depression for people with cancer (SMaRT oncology 1): a randomized trial. Lancet 372 (2008) 40-48
51. Breitbart W., Rosenfeld B., Pessin H., et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 284 (2000) 2907-2911
52. Chochinov H.M., Wilson K.G., Enns M., et al. Depression, hopelessness, and suicidal ideation. Psychosomatics 39 (1998) 366-370
53. Misono S., Weiss N.S., Fann J.R., et al. Incidence of suicide in persons with cancer. J Clin Oncol 26 29 (2008) 4731-4738
54. Miller M., Mogun H., Azrael D., et al. Cancer and the risk of suicide in older Americans. J Clin Oncol 26 29 (2008) 4720-4724
55. Walker J., Waters R.A., Murray G., et al. Better off dead: suicidal thoughts in cancer patients. J Clin Oncol 26 29 (2008) 4725-4730
56. Kendal W.S. Suicide and cancer. Ann Oncol 18 (2007) 381-387
57. Garlow S.J., Purselle D., and Heninger M. Ethnic differences in patterns of suicide across the life cycle. Am J Psychiatry 162 (2005) 319-323
58. Quill T.E., and Cassel C.K. Nonabandonment: a central obligation for physicians. Ann Intern Med 122 (1995) 368-374
59. Vanderwerker L.C., Laff R.E., Kaden-Lottick N.S., et al. Psychiatric disorders and mental health service use among caregivers of advanced cancer patients. J Clin Oncol 23 (2005) 6899-6907
60. Rhee Y.S., Yun Y.H., Park S., et al. Depression in family caregivers of cancer patients: the feeling of burden as a predictor of depression. J Clin Oncol 26 (2008) 5890-5895
61. Braun M., Mikulincer M., Rydall A., et al. Hidden morbidity in cancer: spouse caregivers. J Clin Oncol 25 (2007) 4829-4834
62. Northouse L.L., Templin T., and Mood D. Couples adjustment to breast disease during the first year following diagnosis. J Behav Med 24 (2001) 115-136
63. Portteus A., Ahmad N., Tobey D., et al. The prevalence and use of antidepressant medication in pediatric cancer patients. J Child Adolesc Psychopharmacol 16 4 (2006) 467-473
64. U.S. Food and Drug Administration. Antidepressant use in children, adolescents, and adults (2007), Food and Drug Administration, Center for Drug Evaluation and Research, Rockville (MD)
65. Pfefferbaum-Levine B., Kumor K., Cangir A., et al. Tricyclic antidepressants for children with cancer. Am J Psychiatry 140 8 (1983) 1074-1076
66. Coffey B.J. Review and update: benzodiazepines in childhood and adolescence. Psychiatr Ann 23 6 (1993) 332-339
67. Neron S., Correa J.A., Dajczman E., et al. Screening for depressive symptoms in patients with unresectable lung cancer. Support Care Cancer 15 (2007) 1207-1212
68. Block S.D. Assessing and managing depression in the terminall ill patient. ACP-ASIM End-Of-Life Care Consensus Panel. American college of Physicians-American Society of Internal Medicine. Ann Intern Med 132 (2000) 209-218
69. Cox J.L., Holden J.M., and Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150 (1987) 782-786
70. Lloyd-Williams M., Shiels C., Dowrich C., et al. The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord 99 (2007) 259-264
71. Richardson L.A., and Jones G.W. A review of the reliability and validity of the edmonton symptom assessment system. Curr Oncol 16 1 (2009) 53-64
72. Jefford M., Mileshkin L., Richards K., et al. Rapid screening for depression-validation of the brief case-find for depression (BCD) in medical oncology and palliative care patients. Br J Cancer 91 (2004) 900-906
73. Hahn C., Dunn R., Halperin E.C., et al. Routine screening for depression in radiation oncology patients. Am J Clin Oncol 27 5 (2004) 497-499
74. Fisch M.J., Loehrer P.J., Kristeller J., et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 21 10 (2003) 1937-1943
75. Holland J.C., Romano S.J., Heiligenstein J.H., et al. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 7 (1998) 291-300
76. Lydiatt W., Denman D., McNeilly D., et al. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Arch Otolaryngol Head Neck Surg 134 5 (2008) 528-535
77. Kim S.W., Shin I.S., Kim J.M., et al. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin Neurosci 62 (2008) 75-83
78. Razavi D., Kormoss N., Collard A., et al. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. J Int Med Res 27 (1999) 264-272
79. Purohit D.R., Naviakha P.L., Modi R.S., et al. The role of antidepressants in hospitalized cancer patients. J Assoc Physicians India 26 (1978) 245-248
80. Eija K., Tiina T., and Pertti N.J. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer patients. Pain 64 (1996) 293-302